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Abstract: 
A set of short peptide sequences susceptible to fibrillar aggregation produces sequneces capable of arresting elongation of amyloid 
fibrils. The “stop” signals are short helices customized for each individual target. Such a helix should exhibit high amphiphilicity, 
with differing conditions present on each side (one side should be highly hydrophilic to enable water to interact with the aggregate, 
while the other side must retain a local distribution of hydrophobicity which matches that of the terminal portion of the fibril). The 
emergence and elongation of fibrillary forms resulting from linear propagation of local hydrophobicity peaks is shown using the 
fuzzy oil drop model. 
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Background: 
An important voice in the discussion regarding Alzheimer’s 
disease comes from the psychologist community, which 
attempts to identify objective causes for the disase [1]. Clinicians 
tend to base their diagnoses on the pathological amassment of 
amyloid-β (Aβ) plaques in the central nervous system [2]. The 
involvement of gangliosides and cholesterol in forming 
amyloids is based on a common mechanism [3], leading to the 
conclusion that a universal therapeutic process targeting 
neurodegenerative diseases may be devised. A comprehensive 
discussion of the so-called Energetic Funnel pathway, founded 
upon thermodynamic principles, which likens the folding 
process to the search for an internal energy minimum, of the 
role of chaperones and chaperonins in the folding process and 
of the relation between the structural stability of proteins and 
pathological processes implicated in misfolding diseases is 
discussed elsewhere [4]. The work also highlights therapeutic 
options – such as therapeutic inhibition of precursor protein 
synthesis through expanding the use of RNA interference 
(RNAi). Other notable approaches to drug discovery include 
research into chaperone expression and vaccines [5]. 
Nevertheless, the most promising avenue of research appears to 
involve short synthetic peptides containing the self-recognition 
motif of the protein and engineered to destabilize the abnormal 
conformation, which might be useful to correct protein 
misfolding [6]. Such peptides are sometimes referred to as mini-
chaperones. They exhibit affinity for areas responsible for self-
association and contain residues that specifically favor or 
disfavor a particular structural motif. The use of polyphenols is 
reported elsewhere [7] on the basis of hydrophobic arguments. 
Enzymes capable of breaking up amyloids [8], study the 
possible applications of nanoparticles in misfolding disease 
treatment [9] or investigate the properties of cyclic cis-locked 
phosphor-dipeptides are also known [10]. Physical methods 
include femtosecond laser-induced nanoexplosion of gold 
nanorods [11], while clearance and degradation of amyloid β 
peptides was observed with the use of anti-inflammatory 
Annexin A1 [12]. It was further noted that aducanumab (a 
human monoclonal antiboty) reduces Aβ plaques in 
Alzheimer’s disease [13]. The search for novel drugs is not, 
however, based on amyloid plaque formation mechanisms. 
According to the fuzzy oil drop model [14] (FOD) the water 
environment plays a decisive role in this process – as indeed 
noted by other authors who recognize the importance of 
hydrophobic interactions for amyloid formation. Research into 
structural properties of water is carried out on both theoretical 
[15] and experimental grounds [16]. The external environment is 
also recognized as a factor in amyloidogenesis [17].  
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The fuzzy oil drop model describes the existence of a 
hydrophobic core, with hydrophobic residues congregating at 
the center of the molecule and hydrophilic residues exposed on 
the surface. This type of structure favors interaction with water 
[14], while any local deviations from the theoretical distribution 
of hydrophobicity (mathematically expressed by a 3D Gaussian) 
are suspected of mediating biological activity. More specifically, 
local hydrophobicity deficiencies usually correspond to ligand 
binding sites [18], while areas of excess hydrophobicity, if 
present on the surface, may indicate complexation sites for 
other proteins with similar characteristics [19]. Such local 
discordances are likened to the “iceberg” model were means of 
communication between molecules in water is discussed [20]. 
 
The fuzzy oil drop model also reveals another type of 
discordance versus the theoretical monocentric hydrophobic 
core: linear propagation of local hydrophobicity peaks 
interspersed by local minima. This situation occurs when the 
polypeptide (or polypeptides) is unable to fold as an individual 
molecule with a monocentric FOD-compliant hydrophobic core, 
and instead folds in a way, which is dependent only on the 
intrinsic hydrophobicity of each individual residue. If the 
resulting fragment is placed in the proximity of other similarly 
folded fragments, linear propagation becomes highly likely. As 
shown in [21], once linear propagation sets in, a “stop” signal is 
needed to halt it [22]. Such stop signals have indeed been 
identified in the structures of many proteins whose native forms 
comprise elongated cylinder-like fragments, e.g. solenoids. 
Clearly, evolution has devised ways to prevent unchecked 
linear propagation of protein chains. On the basis of this 
observation we have designed several peptides that serves as 
“stoppers” for the amyloid-forming chains are listed [23]. 
 
Methodology: 
Dataset: 
We base our study on the set of amyloid-forming popetides 
discussed in [23] and treated as targets for the design of 
stoppers, which would prevent elongation of amyloid fibrils. 
The target proteins are listed in Table 1. 
 
The pattern for the design of a “stop” signal is provided by a 
lyase – bacterial chondroitinase b pectate lyase (PDB ID: 1DBG) 
[32]. This protein contains a solenoid fragment with a notably 
linear arrangement of hydrophobic and hydrophilic “bands”. 
This type of structure might propagate indefinitely in the 
absence of an amphiphilic helical stopper, whose hydrophilic 
side faces the water environment while the hydrophobic side 
remains in contact with the fibril. Thus, the protein does not 
readily form complexes or grow indefinitely. 
 
Fuzzy oil drop model: 
The fuzzy oil drop model has been described in detail elsewhere 
[33, 34]. According to the model, the theoretical distribution of 
hydrophobicity in a protein body can be modeled by a 3D 
Gaussian, which peaks at the center of the encapsulating 
ellipsoid. Proteins that conform to this model with good 
accuracy include titin [35] as well as antifreeze class II [36] and 
downhill proteins [37]. An in-depth study of all domains 
present in the PDB database (nonredundant set [38]) revealed 
that the vast majority of individual domains in a way which 
ensures compliance with the theoretical Gaussian distribution. 
This does not, however, rule out the presence of discordances 
and deviations – indeed, local departures from the theoretical 
hydrophobicity distribution often correspond to ligand binding 
sites [18] or complexation sites, capable of attracting other 
proteins to a hydrophilic interface zone [19]. 
 
Table 1: Dataset of peptides and proteins used in this study as 
obtained from elsewehere [23].   
Peptide  Sequence Characteristics Ref 
1YJP Prion GNNQQNY parallel [24] 
2Y3J Amyloid  Β  AIIGLM parallel [25] 
3FPO Islet amyloid 
polypeptide 
HSSNNF parallel [26] 
3LOZ macroglobul
in 
LSFSKD antiparallel [27] 
3NVE prion MMHFGN antiparallel [28] 
2Y3K Amyloid Β MVGGVVIA antiparallel [25] 
3NHC Prion  GYMLGS antiparallel [29] 
2MVX Amyloid 
42aa 
11-42 amyloid [30] 
2MXU Amyloid 
42aa 
11-42 amyloid [31] 
1DBG Lyase   solenoid [32] 
 
Unlike globular proteins, amyloid-like structures do not exhibit 
a monocentric distribution of hydrophibicity. Instead, the local 
distribution in each unit structure is determined solely by the 
intrinsic properties of its constituent residues. Environment 
containing another peptide with a different sequence yet a 
similar distribution of hydrophobicity results in complexation. 
Analysis of amyloid fibril structures [31] reveals linear 
propagation of hydrophobicity peaks interspersed by local 
troughs, usually along the axis of the fibril. 
 
A “stopper” fragment arrests linear aggregation. A putative 
drug that exploits this concept would have to fulfill several 
conditions and be adapted to the specific sequence of its 
“target” fragment. The proposed drug design model is based on 
naturally occurring amyloid-like sequences, which have 
evolved the corresponding “stop” signals preventing 
unrestricted propagation. The underlying mechanism is 
discussed in detail elsewhere [22]. 
 
Amphiphilicity and stability of the helix: 
The proposed helical stopper should, as a rule, be compatible 
with the local hydrophobicity distribution of the unit structure 
of the amyloid fibril; however it must also fulfill another 
condition –propensity for adopting helical, β and random coil 
conformations for a range of sequences [39]. We used the 
information contained in the referenced database [39] to select 
sequences, which exhibit a clear preference for helical forms. 
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Results & Discussion: 
Identification of amyloid forms: 
We show the distribution of hydrophobicity in the 32-residue 
amyloid β a4 protein (2MXU – 11-42) [31]. As shown in Figure 1, 
the observed distribution of hydrophobicity is dominated by the 
intrinsic properties of each residue and does not conform to the 
monocentric core model as expected by idealized 3D-Gauss 
distribution of hydrophobicity (blue line on Figure 1.).  
 
Analysis of distribution profiles suggests linear propagation of 
local hydrophobicity peaks and troughs. This type of structure, 
devoid of any “stop” signal, would tend to propagate 
indefinitely. The observed attenuation of hydrophobicity peaks 
in terminal fragments of the complex and it is caused by the 
lack of another adjacent peptide. It does not ensure “closure” 
which would enable the structure to remain water-soluble. 
 
Such linear propagation of two distinct local maxima (Figures 
1B and 1C) discordant versus the theoretical one needs to be 
arrested if the protein is to retain its biological function 
(comparison of blue line – theoretical distribution – with the 
observed one – red line – which is highly accordant in respect to 
intrinsic hydrophobicity – green line).  It should be noted that 
the neighbouring polypeptide chains represent exactly the same 
hydrophobicity distribution producing the linear propagation.  
 
A “stop” signal for solenoids: 
Solenoids exhibit linear propagation of local hydrophobicity 
distributions, stretching along their axis. Since such forms are 
present in naturally occurring proteins, evolution must have 
come up with a way to counteract their unrestricted 
propagation. This role falls to a “stop” signal, such as the one 
present in bacterial chondroitinase b pectate lyase (PDB ID: 
1DBG) [31]. We use this structure as a pattern for designing 
additional polypeptides, which play an identical role with 
respect to other fibrils. The structure of solenoids is discussed in 
[22]. Here, we focus on the immediate neighborhood its 
bracketing “stop” fragments (note that by “neighborhood” we 
specifically mean the full cyclically occurring structural motif 
adjacent to each “stop” fragment). It is our understanding that 
the “stop” fragment must arrest propagation of the linear 
structure, rendering it capable of interaction with water and 
thereby counteracting further elongation. Figure 2 presents a 
graphical depiction of the strongly amphiphilic helix which 
functions as a “stop” fragment. Since all of its hydrophilic 
residues face the water environment, no further linear 
propagation of local hydrophobicity peaks is possible. 
 
Artificially designed “stop” signals for amyloid peptides: 
According to the fuzzy oil drop model, linear propagation of 
fibrils is facilitated by the following phenomena: (1) lack of 
monocentric hydrophobic core described by a 3D Gaussian; (2) 
repeatable sequence with alternating hydrophobicity peaks and 
troughs; (3) distribution of hydrophobicity dominated by the 
intrinsic properties of each residue; (4) linear propagation of 
hydrophobicity along a given axis 
 
In order to counteract propagation, the following conditious 
should be satisfied: (1) the fibril’s terminal fragments, along 
with an adjoining “stop” signal, should be characterized by RD 
< 0.5, indicating a local distribution of hydrophobicity 
consistent with the Gaussian model; (2) The “stop” signal 
should adopt the form of an amphipathic helix; (3) the outward 
(water-facing) side of the helix should be strongly hydrophilic; 
(4) the inward (fibril-facing) side should have a distribution of 
hydrophobicity consistent; with that of the target peptide. We 
used peptides identified as strongly amyloidogenic as reported 
elsewhere in this study [23]. 
 
Target peptide of the sequence AIIGLM (PDB ID: 2Y3J): 
The sequence present in 2Y3J (PDB ID) is characterized by a 
distribution of hydrophobicity, which closely corresponds to the 
one in 1DBG (PDB ID). Accordingly, the 1DBG “stop” signal 
appears to work equally well in 2Y3J. In light of the above, the 
“stopper” sequence adapted for 2J3Y should be as follows: 
VNETLYQVVKEV (Figure 3). The residues with the 
hydrophobicity parameter above 0.5 are expected to contact the 
hydrophobic residues in target peptide, while the residues of 
hydrophobicity below 0.5 exposed toward the water 
environment.  
 
Target peptide of the sequence HSSNNF (PDB ID: 3FPO): 
The HSSNNF sequence is characterized by local maxima on 
both sides, with relatively low hydrophobicity in the middle. 
The proposed stopper sequence is VNSNAAQAAKNV (Figure 
4). The AAQA and AAKN tetrapeptides tend to adopt helical 
conformations, as noted in Chseq [39].  
 
Target peptide of the sequence LSFSKD (PDB ID: 3LOZ): 
The next target peptide is LSFSKD (3LOZ), with a distribution 
shown in Figure 5. In this case, we’re dealing with a fairly 
prominent central peak, separated from another distal peak by a 
shallow trough (residue #2). This information is sufficient to 
porpose a suitable stopper helix. The proposed sequence is 
VNELTLQAAKSA (Figure 5), with three strongly helical 
tetrapeptides (according to Chseq [lit]): ELTL, TLQA and 
LQAA.  
 
Target peptide of the sequence MMHFGN (PDB ID: 3NVE): 
For the MMHFGN target peptide (3NVE), the matching stopper 
sequence is VNETTAQAVKEV (Figure 6). This sequence 
contains four helical tetrapeptides: TTAQ, TAQA, AQAV and 
AVKE.  
 
Target peptide of the sequence GYMLGS (PDB ID: 3NHC): 
Here, a similar stoper to the one designed for 1DBG might 
successfully arrest propagation (Figure 7). The general 
conclusion regarding “stop” signals is that while dimerization 
remains a concern, solubility should remain high in all cases. 
 
Designing stoppers for dual β-fibrils: 
It is interesting to consider potential stoppers adapted to 
Aβamyloids, such as the ones present in 2MVX and 2MXU. 
Figure 8 provides a visual depiction of this case, listing the 
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separation and proportions of all fragments, which a suitably 
designed helix should bracket. 
 
Proposed helical stopper for 2MVX: 
The proposed sequence for a helix which could potentially 
obstruct the 10-20 aa section in 2MVX is as follows: 
SNETLYQVVKE(V)ASNETLYQVVKEA(V). It is a fairly long 
helix that can span the entire length of the β-fragment. We 
believe that any shorter fragment of this helix may be sufficient 
as a stopper to avoid unwanted immune reaction. The sequence 
is based on the 1DBG template, with a single change marked by 
square brackets. The introduction of an Ala residue is dictated 
by the need to reduce hydrophobicity compared to the original 
Val residue. This substitution has been verified to increase the 
sequence’s affinity for adopting helical conformations. Figure 9 
illustrates the local distribution of hydrophobicity in each β-
fragment and the corresponding distribution in the proposed 
helix. 
 
 
Figure 1. Theoretical (blue) and observed (red) and intrinsic 
(green) distribution of hydrophobicity in A - the entire complex 
(2MXU); B – chain F 24-32; C - chain E 12-18.  
 
Proposed helical stopper for (PDB ID: 2MXU): 
In this amyloid we can discern two potential anchoring points 
for a stop signal (Figure 10). The corresponding profile for the 
proposed helix is illustrated in Figure 10. Designing additional 
helical stoppers based on the 1DBG template and fulfilling all 
the previously stated criteria should be relatively trivial for 
verification. 
 
Other types of “stop” signals: 
Our analysis of the terminal sections of linearly ordered 
fragments revealed some very short bracketing folds, whose 
length does not exceed half the length of the blocked peptide. It 
seems that such short β-fragments may also play the role of a 
“stop” signal are as long as they disrupt the regular ordering of 
local hydrophobicity peaks, preventing the attachment of 
another unit peptide (Figure 11). 
 
 
Figure 2. STOP fragment’s 3D presentation. Dark blue are 
hydrophilic residues, red are hydrophobic residues. Top row 
are transparent all-atom model, bottom row – surface 
presentation. The structure is viewed from three different 
perspectives angles: A, D – horizontal orientation of helix seen 
from the environment site; B, E – helix perpendiculal versus the 
paper surface, C, F - the “cap” seen from the solenoid 
perspective. 
 
 
Figure 3. Distribution of hydrophobicity based on the intrinsic 
properties of residues comprising the AIIGLM (2Y3J). (A) 
Distribution of hydrophobicity in the target peptide (parallel 
arrangement). Dashed line separates the hydrophobic (values 
above 0.5) and hydrophilic (values below 0.5) residues to mach 
the distribution in the target peptide. (B) Compatible 
distribution of hydrophobicity in the postulated helix that 
would attach itself to the fibril. The upper sequence – sequence 
of the helix as it is present in 1DBG. The lower sequence – 
proposed as stopper for AIIGLM target peptide sequence. 
Dashed lines distinguish the high hydrophobicity positions 
(above 0.5) and low hydrophobicity parameters (below 0.5). The 
residues with hydrophobicity above 0.5 assumed to interact 
with target peptide, the residues below 0.5 exposed toward the 
water environment.  
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Figure 4. Distribution of hydrophobicity based on the intrinsic 
properties of residues comprising the HSSNNF fragment 
(3FPO). (A) Distribution of hydrophobicity in the target peptide 
(parallel arrangement). (B) Compatible distribution of 
hydrophobicity in the postulated helix that would attach itself 
to the fibril. The green line is the hydrophobicity distribution in 
the pattern helix (1DBG – upper sequence along the X-axis). The 
magenta line – distribution modified to make the sequence 
compatible to the target sequence in 3FPO (sequence proposed – 
lower line below the X-axis). Dashed lines explained in Figure 3.  
 
 
Figure 5. Distribution of hydrophobicity based on the intrinsic 
properties of residues representing the LSFSKD polypeptide 
(3LOZ). (A) Distribution of hydrophobicity (parameters) in the 
target peptide. (B) Compatible distribution of hydrophobicity in 
the postulated helix, which would attach itself to the fibril. 
Green line is hydrophobicity distribution in pattern helix 
(1DBG) (upper sequence below the X-axis), pink line – 
postulated distribution of hydrophobicity for the helix 
interacting with target peptide (sequence given in the lower line 
below the X-axis). Dashed lines explained in Figure 3.   
 
Drugs proposed by other authors: 
It is difficult to properly discuss the stoppers proposed in [40 - 
42] since the cited papers lack a clear description of the target 
peptides. Of note is the high density of polar residues, which 
might encourage contact with water; however no information 
regarding the compatibility of the hydrophobic side of the 
stopper with the target peptide. AEVVFT and TAVVTN [40]. 
According to the data in [40, 41], the authors assume that the 
peptide will adopt a β-conformation. This may indeed occur as 
the peptide aligns itself with the target; however it seems that 
such peptides may be effective only for certain selected target 
sequences. The short β-strand highly compatible with respect to 
β-stand in target fibrillar molecule is shown in 1DAB. This short 
β-strand should be of 1/3 or even less of the length of the target 
β-strand.  
 
 
Figure 6. Distribution of hydrophobicity based on the intrinsic 
properties of residues comprising the MMHFGN fragment 
(3NVE). (A) Distribution of hydrophobicity in the target peptide 
(3NVE). (B) Hydrophobicity distribution as postulated for the 
helix that is expected to attach itself to the fibril. Dashed lines 
explained in Figure 3. 
 
 
Figure 7. Distribution of hydrophobicity based on the intrinsic 
properties of residues comprising the GYMLGS fragment 
(3NHC). (A) Distribution of hydrophobicity in the target 
peptide. (B) Compatible distribution of hydrophobicity in the 
postulated helix that would attach itself to the fibril. Dashed 
line explained in Figure 3. 
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Figure 8. Comparison of separation distances and lengths in 
target peptides: (A) 1DBG – template used in the design of the 
proposed stoppers (3D visualization of helix together with the 
target β-peptides); (B) 2MXU  – in this case two potential 
anchoring points for a “stop” helix are present; (C) 2MVX – 
here, we focus on two sites: a double β-fragment and a long 
individual β-fragment; Red – helical fragments expected to be 
anchored to the β-structural fragments (yellow).  
 
 
Figure 9: Comparison of hydrophobicity profiles in the 
proposed “stop” helix and the corresponding β structure in 
2MVX (10-20 aa). Red line indicates corresponding residues 
with compatible hydrophobic interactions. Green line is the 
pattern sequence as appears in 1DBG. Dashed lines explained in 
Figure 3. 
 
 
Figure 10. Observed (O - green) and intrinsic (H-red) 
hydrophobicity distribution profiles for the β-fragments in 
2MXU. The yellow fragments are β-fragments.  
 
 
Figure 11. Examples of solenoids terminated by very short β-
fragments (red fragments) (C-terminal in 4YZA and the N-
terminal fragment in 1DAB). 
 
Conclusions: 
Drug like inhibitors: Peptides with short helix should (1) easily 
interact with fragments which sustain propagation in fibrils; (2) 
include hydrophilic elements which enable contact with water 
and prevent indefinite propagation of linear forms; (3) avoid 
self-association; (4) exhibit a tendency to form an amphiphatic 
helical conformation, with the hydrophobic side attached to the 
fibril (if possible, with high selectivity versus the target 
molecule of fibril) and the hydrophilic side facing the water 
environment – such as in 1DBG. 
 
An ampiphatic helix with hydrophobic residues facing the fibril 
and hydrophilic residues facing the water environment creates a 
“bridge” between the hydrophobic portion of the fibril and the 
environment. Note that a helical peptide is typically stable in its 
isolated form, whereas the stability of an isolated β-strand 
cannot be ensured. Known peptides discussed elsewhere [40-42] 
fulfill some of the conditions specified above. It should also be 
noted that in order to function as a drug, the peptides should 
resist dimerization and avoid triggering an immune response.  
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